Table 1 Characteristics of five study subjects with large central scars and visual improvement between months 3 and 12

From: Improvement in corneal scarring following bacterial keratitis

ID Age Sex SCUT Tx Organism BSCVA BCLVA
      0 Month 3 Months 12 Months 3 Months 12 Months
1 50 F Placebo S. pneumoniae CF 20/159 20/38 20/69 20/29
2 43 M Placebo S. pneumoniae HM 20/240 20/66 20/132 20/55
3 63 M Steroid S. pneumoniae CF 20/289 20/69 20/289 20/42
4 65 M Steroid S. pneumoniae CF 20/96 20/28 20/80 20/25
5 30 F Steroid P. aeruginosa HM 20/145 20/26 20/126 20/24
  1. BCLVA, best visual acuity after correction with rigid gas permeable contact lens; BSCVA, best spectacle–corrected visual acuity; CF, counting fingers; HM, hand motions; SCUT Tx, treatment group in the Steroids for Corneal Ulcers Trial.3, 4